1. Home
  2. ARDX vs MSBI Comparison

ARDX vs MSBI Comparison

Compare ARDX & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.02

Market Cap

797.8M

Sector

Health Care

ML Signal

N/A

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

N/A

Current Price

$33.24

Market Cap

684.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ARDX
MSBI
Founded
2007
1881
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
797.8M
684.0M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
ARDX
MSBI
Price
$3.02
$33.24
Analyst Decision
Strong Buy
Hold
Analyst Count
11
5
Target Price
$12.80
★ $34.75
AVG Volume (30 Days)
★ 4.3M
124.9K
Earning Date
11-03-2026
10-22-2026
Dividend Yield
N/A
★ 3.96%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.51
Revenue
★ $2,607,000.00
N/A
Revenue This Year
$19.21
$3.01
Revenue Next Year
$28.19
$1.58
P/E Ratio
★ N/A
$13.27
Revenue Growth
N/A
★ N/A
52 Week Low
$2.96
$15.06
52 Week High
$8.40
$35.10

Technical Indicators

Market Signals
Indicator
ARDX
MSBI
Relative Strength Index (RSI) 40.04 49.66
Support Level N/A $31.73
Resistance Level $3.35 $33.84
Average True Range (ATR) 0.12 0.88
MACD 0.01 0.06
Stochastic Oscillator 25.32 44.37

Price Performance

Historical Comparison
ARDX
MSBI

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

Share on Social Networks: